SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-006396
Filing Date
2023-03-01
Accepted
2023-03-01 16:15:44
Documents
20
Period of Report
2023-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 61860
2 ex2-1.htm EX-2.1 205155
3 ex10-1.htm EX-10.1 172413
4 ex10-2.htm EX-10.2 1250405
5 ex10-3.htm EX-10.3 98380
6 ex99-1.htm EX-99.1 20333
7 ex-a_001.jpg GRAPHIC 16108
8 ex99-1_002.jpg GRAPHIC 3119
9 ex99-1_001.jpg GRAPHIC 2589
  Complete submission text file 0001493152-23-006396.txt   2316491

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE xtnt-20230228.xsd EX-101.SCH 3239
11 XBRL LABEL FILE xtnt-20230228_lab.xml EX-101.LAB 34916
12 XBRL PRESENTATION FILE xtnt-20230228_pre.xml EX-101.PRE 22797
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3704
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 23693703
SIC: 2836 Biological Products, (No Diagnostic Substances)